239 related articles for article (PubMed ID: 16227099)
21. Oral pigmentation in the hard palate associated with imatinib mesylate therapy: a report of three cases.
Mattsson U; Halbritter S; Mörner Serikoff E; Christerson L; Warfvinge G
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):e12-6. PubMed ID: 21330162
[TBL] [Abstract][Full Text] [Related]
22. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
[TBL] [Abstract][Full Text] [Related]
23. Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib.
Breccia M; Carmosino I; Russo E; Morano SG; Latagliata R; Alimena G
Eur J Haematol; 2005 Feb; 74(2):121-3. PubMed ID: 15654902
[TBL] [Abstract][Full Text] [Related]
24. [Psoriasis vulgaris exacerbated by imatinib therapy in chronic myelogenous leukemia].
Shimizu K; Kuroda H; Kida M; Watanabe H; Shirao S; Akiyama T; Fujimi A; Tanaka I; Sato T; Matsunaga T; Niitsu Y
Rinsho Ketsueki; 2005 Oct; 46(10):1152-5. PubMed ID: 16440780
[TBL] [Abstract][Full Text] [Related]
25. Follicular acneiform eruption induced by imatinib.
Martín JM; Jordá E; Monteagudo C; Alonso V; García L; Villalón G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1368-70. PubMed ID: 17062082
[No Abstract] [Full Text] [Related]
26. Skin fragility and blistering with imatinib mesylate.
Verma SM; Murphy G
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):496-8. PubMed ID: 19925597
[No Abstract] [Full Text] [Related]
27. Extramedullary blast crises in CML patients in complete hematological remission treated with imatinib mesylate.
Simpson E; O'Brien SG; Reilly JT
Clin Lab Haematol; 2006 Jun; 28(3):215-6. PubMed ID: 16706941
[No Abstract] [Full Text] [Related]
28. [Intestinal bleeding during the treatment of chronic myeloid leukemia with imatinib mesylate].
Yokote T; Akioka T; Nakayama S; Oka S; Hara S; Yamano T; Tsuji M; Hanafusa T
Rinsho Ketsueki; 2005 Sep; 46(9):1060-4. PubMed ID: 16440765
[TBL] [Abstract][Full Text] [Related]
29. Ocular side effects in chronic myeloid leukemia patients treated with imatinib.
Breccia M; Gentilini F; Cannella L; Latagliata R; Carmosino I; Frustaci A; Alimena G
Leuk Res; 2008 Jul; 32(7):1022-5. PubMed ID: 18061664
[TBL] [Abstract][Full Text] [Related]
30. Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy.
Dib EG; Ifthikharuddin JJ; Scott GA; Partilo SR
Leuk Res; 2005 Feb; 29(2):233-4. PubMed ID: 15607374
[No Abstract] [Full Text] [Related]
31. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
32. Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis.
Rosado MF; Donna E; Ahn YS
J Clin Oncol; 2003 Aug; 21(16):3171-3. PubMed ID: 12915610
[No Abstract] [Full Text] [Related]
33. [Imatinib-induced DRESS].
Goldman J; Duval-Modeste AB; Lambert A; Contentin N; Courville P; Musette P; Joly P
Ann Dermatol Venereol; 2008 May; 135(5):393-6. PubMed ID: 18457727
[TBL] [Abstract][Full Text] [Related]
34. Imatinib mesylate induced skin hypopigmentation.
Talwar V; Doval DC; Bhatia K
J Assoc Physicians India; 2007 Jul; 55():527. PubMed ID: 17907508
[No Abstract] [Full Text] [Related]
35. Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss.
François H; Coppo P; Hayman JP; Fouqueray B; Mougenot B; Ronco P
Am J Kidney Dis; 2008 Feb; 51(2):298-301. PubMed ID: 18215707
[TBL] [Abstract][Full Text] [Related]
36. Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.
Kim M; Lee S; Jung CK; Lim J; Cho SG; Kim DW; Kim Y; Han K; Min WS; Kim CC
Int J Lab Hematol; 2008 Dec; 30(6):508-12. PubMed ID: 18983302
[TBL] [Abstract][Full Text] [Related]
37. Oral lichenoid eruption associated with imatinib treatment.
Gómez Fernández C; Sendagorta Cudós E; Casado Verrier B; Feito Rodríguez M; Suárez Aguado J; Vidaurrázaga Díaz de Arcaya C
Eur J Dermatol; 2010; 20(1):127-8. PubMed ID: 19825526
[No Abstract] [Full Text] [Related]
38. Livedoid skin reaction probably due to imatinib therapy.
Martínez-González MC; del Pozo J; Yebra-Pimentel MT; Pérez M; Almagro M; Fonseca E
Ann Pharmacother; 2007 Jan; 41(1):148-52. PubMed ID: 17190842
[TBL] [Abstract][Full Text] [Related]
39. A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients.
Brazzelli V; Prestinari F; Barbagallo T; Rona C; Orlandi E; Passamonti F; Locatelli F; Zecca M; Villani S; Borroni G
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):384-7. PubMed ID: 17309464
[TBL] [Abstract][Full Text] [Related]
40. Imatinib mesylate-induced pseudoporphyria.
Berghoff AT; English JC
J Am Acad Dermatol; 2010 Jul; 63(1):e14-6. PubMed ID: 20542169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
